Co-designing Personalised Assistive Technology

计划入组 15 人 · 首次发布于 2021 年 4 月 8 日

Bio-HPP vs Cast Co-cr as Implant Framework

计划入组 15 人 · 首次发布于 2023 年 5 月 16 日

Shanghai Meiji Health Science and Technology Co., Ltd

计划入组 95 人 · 首次发布于 2020 年 12 月 3 日

UMSC-01

CIK(Ever Supreme Bio)

ADCV-01

EVER SUPREME BIO TECHNOLOGY CO., LTD.

Taiwan

Health Ever Bio-Tech Co., Ltd.

Taiwan

Brightgene Bio-Medical Technology Co., Ltd.

China

Myocardial Infarction: Promising Therapies Advance Through Clinical Trials

Ever Supreme's Allogeneic CAR-T CAR001 Clears Phase I Safety Review, Advances to Phase IIa in Solid Tumors

Ever Supreme's Allogeneic Solid Tumor CAR-T CAR001 Advances to Phase IIa, Targets 2028 Taiwan Provisional Approval